RSV activity in Poland
Current respiratory syncytial virus (RSV) activity in Poland, based on ECDC ERVISS weekly data, set against the parallel flu and COVID-19 trajectories.
Influenza: Low
Low
The source currently reports no meaningful activity (as of 16 Aug 2026).
Data window: Week 33 · Aug 10 – Aug 16 · Source: ECDC (weekly) · Source on seasonal break, next data from week 40
Get one free alert when the wave turns in Poland
We write exactly once: the moment the level goes up. No account, no newsletter. We store your address and the country, nothing else. Every mail has a one click unsubscribe. Privacy
View the last 8 weeks
In week 33 of 2026, Influenza activity in Poland is classified as low.
The source reports no meaningful activity across these weeks; a week-over-week percentage would be pure noise here.
The last 8 reported weeks
| Week | Relative | Level | vs prior week |
|---|---|---|---|
| Week 33 | – | Low | – |
| Week 32 | – | Low | – |
| Week 31 | – | Low | – |
| Week 30 | – | Low | – |
| Week 29 | – | Low | – |
| Week 28 | – | Low | – |
| Week 27 | – | Low | – |
| Week 26 | – | Low | – |
Across these weeks the source reports no meaningful activity, the values sit at the floor of its scale.
Current activity
- InfluenzaLowstableWeek 33Trend: stable · Week 33
- COVID-19LowstableWeek 33Trend: stable · Week 33
- RSVLowstableWeek 33Trend: stable · Week 33
What this means
In week 33 of 2026, activity of respiratory syncytial virus (RSV) in Poland is low. The trend, derived from clinical surveillance, is stable.
Data, context and methodology
The current picture for Poland is built on the European Respiratory Virus Surveillance Summary (ERVISS), published weekly by the European Centre for Disease Prevention and Control (ECDC). the National Institute of Public Health (NIZP PZH) via the SENTINEL system is the national public-health authority that feeds ERVISS with sentinel primary care and virology data.
ECDC ERVISS
ERVISS is ECDC's weekly pan-European surveillance summary for influenza, SARS-CoV-2 and RSV. National authorities, in Poland's case the National Institute of Public Health (NIZP PZH) via the SENTINEL system, submit harmonised indicators every week, which ECDC publishes in a standardised dataset on Thursdays. Using ERVISS rather than each country's native portal ensures cross-country comparability.
ILI / ARI consultation rates and positivity
the National Institute of Public Health (NIZP PZH) via the SENTINEL system operates a sentinel network of general practices that report weekly rates of patients consulting for influenza-like illness (ILI) or acute respiratory infection (ARI). A subset of patients is swabbed and tested by reference laboratories, producing pathogen-specific positivity rates for flu, SARS-CoV-2 and RSV.
Why this source
Combining consultation incidence with virological positivity yields a pathogen-specific weekly incidence signal (ILI × positivity / 100). This is the standard European methodology and provides a more robust view than either indicator alone: consultation rates capture illness burden, positivity confirms which pathogen is driving it.
Qualitative classification
The “low”, “moderate” and “high” categories follow seasonal reference values and epidemiological thresholds calibrated to match our classifications for other countries. The ILI × positivity / 100 product is scaled to comparable thresholds using a divisor of 3, which aligns European sentinel peaks with the consultation-equivalent scale used elsewhere. Data refreshes weekly when ECDC publishes the latest ERVISS update, typically on Thursdays.
Source and seasonal pattern by pathogen
- Influenza
- The classification is based on the ECDC ERVISS weekly reports, drawing on sentinel and virological data from the National Institute of Public Health NIH - National Research Institute (NIZP PZH). Seasonally, infection waves in Poland typically peak between January and March; activity is usually markedly lower during the summer months.
- COVID-19
- The classification is based on the ECDC ERVISS weekly reports, drawing on COVID-19 indicators from Poland's National Institute of Public Health NIH - National Research Institute (NIZP PZH). Seasonally, infection waves in Poland typically peak during winter, with occasional summer waves driven by new variants; activity is usually markedly lower in late spring between waves.
- RSV
- The classification is based on the ECDC ERVISS weekly reports, drawing on RSV indicators from Poland's National Institute of Public Health NIH - National Research Institute (NIZP PZH). Seasonally, infection waves in Poland typically peak between December and February; activity is usually markedly lower in spring and summer.
Frequently asked questions
When is RSV season in Poland?
RSV activity in Poland broadly tracks the winter respiratory season, with the main wave typically climbing from late autumn, peaking between January and March, and easing into spring. The exact timing varies from year to year. Post-pandemic seasons have in some cases shifted earlier or produced sharper peaks, a pattern observed across Europe and reflected in ERVISS reporting.
How is RSV monitored in Poland?
NIZP PZH integrates RSV into its respiratory-virus surveillance, using sentinel primary-care sites and reference laboratories to produce weekly indicators of RSV positivity. These feed into ECDC's ERVISS, where RSV is reported alongside influenza and SARS-CoV-2. The combined panel lets Polish authorities track when RSV pressure on paediatric services is building relative to flu.
Who is most at risk from RSV in Poland?
The highest-risk groups in Poland mirror international patterns: infants (especially those under six months and former preterm babies) and adults aged 60 and older, particularly those with chronic cardiopulmonary conditions. In these groups RSV can progress to bronchiolitis or pneumonia requiring hospital care. Preventive antibodies for infants and adult RSV vaccines are now available in Poland for qualifying groups.
How does Poland's RSV signal compare across Europe?
Because Poland reports into ERVISS, its RSV curve can be compared directly with other EU/EEA countries using the same tiered classifications. Polish peaks frequently sit within a few weeks of the central and eastern European cluster. This cross-country view helps clinicians and public-health teams anticipate paediatric admissions pressure before it fully materialises at home.
How does RSV differ from flu in the surveillance data?
Although flu and RSV share a winter footprint in Poland, the RSV signal is dominated by paediatric presentations, bronchiolitis in the very young, while flu affects all age bands more evenly. In ERVISS terms, RSV and influenza are tracked as separate positivity streams within the same respiratory panel. Distinguishing them reliably usually requires a laboratory test; symptom overlap is too wide for a clinical call.
More situation reports
Data last refreshed: Aug 31, 2026, 11:11. Update cadence: weekly.
This page is not medical advice and does not replace consultation with a healthcare professional. For specific symptoms, please contact a medical professional.
About this page
Published by Renderei Martin GmbH, Berlin. No commercial interest in individual health recommendations. The app is optionally monetised via a freemium subscription.
Content is based exclusively on the linked official surveillance publications. Medical statements are curated against the guidance of RKI, ECDC and WHO.
Methodology enquiries: press@infectrisk.com